Illumina rises on upbeat preliminary quarterly revenue

Illumina

09/01/2024 14:33

** Shares of gene-sequencing company Illumina  ILMN.O  rise
3.1% to $137.70 in early trading
    ** Company's preliminary Q4 revenue of $1.12 bln tops Wall
Street estimate of $1.07 bln - LSEG data
    ** ILMN says it shipped 352 NovaSeq X gene sequencing
instruments in FY23, compared with its prior forecast of 330 to
340 instruments for the fiscal year
    ** 10 of 24 brokerages rate the stock "buy" or higher, 11
"hold", 3 "sell"; median PT is $126 - LSEG data
    ** Stock fell 31.1% in 2023

 (Reporting by Puyaan Singh)
 ((Puyaan.Singh@thomsonreuters.com;))